Skip to main content

Hockey Study of former NHL enforcer Todd Ewen’s brain shows no signs of CTE

Boston Bruins Lyndon Byers, left, and Montreal Canadiens Todd Ewen, right, trade punches during a brawl in this file photo.

CP

The mystery behind the degenerative brain disease chronic traumatic encephalopathy (CTE) grew on Wednesday with the release of the brain autopsy results of former NHL enforcer Todd Ewen.

Family and friends were certain that Ewen – who suffered multiple concussions during a 518-game career with four teams, and died by suicide in September – had CTE. But a study by the Toronto-based Canadian Concussion Centre, which has conducted an in-depth study of his brain the past several months, revealed he did not.

Ewen was 49 years old when he died, and had been experiencing memory loss, chronic pain, diabetes and depression.

Story continues below advertisement

"We were very surprised by the results, as we were sure Todd must have had CTE," said Ewen's wife, Kelli, who donated her husband's brain to be studied by the CCC shortly after his death. "We hope that anyone suffering from the effects of concussion takes heart that their symptoms are not an automatic diagnosis of CTE. Depression coupled with other disorders can have many of the same symptoms as CTE."

"These results indicate that, in some athletes, multiple concussions do not lead to the development of CTE," said Dr. Lili-Naz Hazrati, a neuropathologist who helped conduct the examination of Ewen's brain with the CCC research team. "Our findings continue to show that concussions can affect the brain in different ways.

This underlines the need to not only continue this research but also be cautious about drawing any definitive conclusions about CTE until we have more data."

CTE has become synonymous with former NFL players who have experienced debilitating conditions after retirement and died tragically. In recent years, several deceased NHL players – many of them former fighters – have also been found to have had CTE.

"Every time it was announced that a fellow player had CTE, Todd would say: 'If they had CTE, I know I have CTE,'" Kelli Ewen said.

"He was terrified by the thought of a future living with a degenerative disease that could rob him of his quality of life and cause him to be a burden to his family."

It's not known why some athletes who suffered multiple concussions during their careers develop CTE while others do not.

Story continues below advertisement

Neuropathologists such as Boston University's Dr. Ann McKee, a leading CTE expert, theorize that some people might have a genetic predisposition to getting the disease, while others might have a genetic resistance.

As it is not yet possible to test for CTE in the living, despite advancements toward that goal, researchers are relying on the slow process of collecting and analyzing deceased athletes' brains to learn more.

Including Ewen's, the CCC has analyzed 20 brains and roughly half have shown signs of CTE or other neurodegenerative diseases.

The centre was founded by Dr. Charles Tator with the goal of examining 50 donated brains as part of the research project.

"We still need to better understand this disease and the effects of concussions on the brain in order to figure out how to identify those who will develop CTE, as well as help people like Todd Ewen who struggle with symptoms from head injuries," said Dr. Carmela Tartaglia, a neurologist who was also part of the CCC research team.

"It's through these analyses that we hope to find answers."

Story continues below advertisement

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter